Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3879046 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBDGKAEPHX2 | |
| SCHEMBL2303872 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBDGKAEPHX2 | |
| SCHEMBL28390346 | 0.81 | DGKA (0.45) | ALDH1A1DGKAADRA2AADRA1ASMN1; SMN2 | |
| SCHEMBL1108185 | 0.81 | CYP1A2 (0.48) | ALDH1A1TSHRHSD17B10SMN1; SMN2POLB | |
| SCHEMBL1301905 | 0.80 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRBDGKAEPHX2 | |
| SCHEMBL17826741 | 0.79 | ALDH1A1 (0.44) | ALDH1A1TSHRTHRBDGKAEPHX2 | |
| SCHEMBL17998753 | 0.79 | DGKA (0.63) | ALDH1A1TSHRTHRBDGKAEPHX2 | |
| SCHEMBL4250044 | 0.79 | DGKA (0.63) | ALDH1A1TSHRTHRBDGKAEPHX2 | |
| SCHEMBL181434 | 0.79 | ALDH1A1 (0.56) | ALDH1A1TSHRTHRBDGKAEPHX2 | |
| SCHEMBL28392407 | 0.78 | DGKA (0.52) | ALDH1A1TSHRDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9771319-B2 | Cross-linker for the preparation of a new family of single ion conduction polymers for electrochemical devices and such polymers | BELENOS CLEAN POWER HOLDING AG (CH) | 2017-09-26 | — | — | US | disclosed |
| US-20160168086-A1 | NOVEL CROSS-LINKER FOR THE PREPARATION OF A NEW FAMILY OF SINGLE ION CONDUCTION POLYMERS FOR ELECTROCHEMICAL DEVICES AND SUCH POLYMERS | BELENOS CLEAN POWER HOLDING AG (CH) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168086-A1 | NOVEL CROSS-LINKER FOR THE PREPARATION OF A NEW FAMILY OF SINGLE ION CONDUCTION POLYMERS FOR ELECTROCHEMICAL DEVICES AND SUCH POLYMERS | PPOX, PFAS, LPO | ALDH1A1 2449/4885TSHR 4427/4885THRB 4134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.